Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

S&T BANCORP INC (STBA) Stock Forecast 2025 - AI Price Prediction & Analysis

S&T BANCORP INC (STBA) AI Stock Price Forecast & Investment Analysis

S&T BANCORP INC Stock Price Chart and Technical Analysis

Loading S&T BANCORP INC interactive price chart and technical analysis...

S&T BANCORP INC (STBA) - Comprehensive Stock Analysis & Investment Research

Deep dive into S&T BANCORP INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about S&T BANCORP INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For S&T BANCORP INC: S&T BANCORP INC operates in the Finance sector, making it an emerging small-cap investment.

S&T BANCORP INC (Stock Symbol: STBA) is a leading company in the Finance sector , specifically operating within the State Commercial Banks industry.

The organization employs approximately 862 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing S&T BANCORP INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For S&T BANCORP INC: With $291M in annual revenue and 31.9% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $291 million generating a 31.9% net profit margin .

Market Capitalization: $1379 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 9.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for S&T BANCORP INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For S&T BANCORP INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for S&T BANCORP INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: S&T BANCORP INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For S&T BANCORP INC: Strong free cash flow generation demonstrates solid operational efficiency.

S&T BANCORP INC strategically competes in the highly dynamic State Commercial Banks marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $209 million annually, complemented by impressive -61.4% year-over-year cash flow growth.

S&T BANCORP INC (STBA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for S&T BANCORP INC stock analysis.

Loading S&T BANCORP INC comprehensive fundamental analysis and insider trading data...

Deep dive into S&T BANCORP INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if S&T BANCORP INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For S&T BANCORP INC: With a P/E ratio of 14.21, the market sees the stock as potentially undervalued.

P/E Ratio 14.21x
P/B Ratio 0.95x
Market Cap $1379M
Dividend Yield 2.80%
EPS $2.57
Book Value/Share $37.68
Revenue/Share $7.61
FCF/Share $0.97
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently S&T BANCORP INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For S&T BANCORP INC: An ROE of 9.1% indicates room for improvement in shareholder value creation.

ROE 9.1%
ROA 1.1%
Net Margin 31.9%
EBT Margin 39.5%
Tax Rate 18.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess S&T BANCORP INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For S&T BANCORP INC:

D/E Ratio 0.06x
Financial Leverage 7.96x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal S&T BANCORP INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For S&T BANCORP INC: Free cash flow of $209M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $213M
Free Cash Flow $209M
Capital Spending $-3M
OCF Growth YoY -61.4%
FCF Growth YoY -64.0%
FCF/Sales 62.3%
CapEx/Sales 1.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively S&T BANCORP INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For S&T BANCORP INC: An asset turnover of 0.04x suggests room for improvement in asset utilization.

Asset Turnover 0.04x
Fixed Assets Turnover 6.3x
Understanding Financial Statement Data

What these metrics mean: Key figures from S&T BANCORP INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For S&T BANCORP INC: With annual revenue of $291M, S&T BANCORP INC demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $291M
SG&A Expense $38M
Balance Sheet Highlights (% Of Assets)
Cash & Short-term Investments 20%
Total Liabilities 87%
Short-term Debt 1%
Dividend & Shareholder Information
Dividends Per Share $1.02
Payout Ratio 0.4%
Shares Outstanding 38M
Growth Metrics (YoY)
EPS Growth 8.7%

Latest S&T BANCORP INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting S&T BANCORP INC (STBA) stock price and investment outlook.

S&T BANCORP INC Competitors & Peer Analysis - Finance Sector

Comparative analysis of S&T BANCORP INC against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABCB Unlock Forecast - 30 Days FREE Trial $4987M 13.0x 1.3x
ACNB Unlock Forecast - 30 Days FREE Trial $471M 18.9x 1.2x
AMAL Unlock Forecast - 30 Days FREE Trial $839M 8.3x 1.2x
ASB Unlock Forecast - 30 Days FREE Trial $4118M 30.5x 0.9x
ASBA Unlock Forecast - 30 Days FREE Trial $4083M 29.3x 0.9x
ASB-PE Unlock Forecast - 30 Days FREE Trial $3566M 25.6x 0.8x
ASB-PF Unlock Forecast - 30 Days FREE Trial $3515M 25.2x 0.7x
AUB Unlock Forecast - 30 Days FREE Trial $4650M 23.8x 1.0x
AUB-PA Unlock Forecast - 30 Days FREE Trial $3481M 17.1x 0.7x
BAFN Unlock Forecast - 30 Days FREE Trial $39M 4.2x 0.4x
BANR Unlock Forecast - 30 Days FREE Trial $2123M 12.1x 1.1x
BCML Unlock Forecast - 30 Days FREE Trial $297M 12.6x 0.9x
BFST Unlock Forecast - 30 Days FREE Trial $732M 9.6x 0.9x
BHB Unlock Forecast - 30 Days FREE Trial $451M 12.0x 1.0x
BK Unlock Forecast - 30 Days FREE Trial $77486M 15.5x 1.8x
BK-PK Unlock Forecast - 30 Days FREE Trial $18771M 3.8x 0.4x
BKSC Unlock Forecast - 30 Days FREE Trial $88M 13.5x 2.1x
BMRC Unlock Forecast - 30 Days FREE Trial $424M 57.1x 1.0x
BOH Unlock Forecast - 30 Days FREE Trial $2563M 14.9x 1.4x
BOH-PA Unlock Forecast - 30 Days FREE Trial $671M 3.9x 0.4x
BOH-PB Unlock Forecast - 30 Days FREE Trial $1027M 6.0x 0.6x
BOTJ Unlock Forecast - 30 Days FREE Trial $72M 10.0x 1.0x
BPOP Unlock Forecast - 30 Days FREE Trial $7421M 10.7x 1.3x
BPOPM Unlock Forecast - 30 Days FREE Trial $1709M 2.4x 0.3x
BPOPO Unlock Forecast - 30 Days FREE Trial $1702M 2.4x 0.3x
BPRN Unlock Forecast - 30 Days FREE Trial $210M 30.7x 0.8x
BSRR Unlock Forecast - 30 Days FREE Trial $401M 9.2x 1.1x
BSVN Unlock Forecast - 30 Days FREE Trial $393M 9.2x 1.7x
BUSE Unlock Forecast - 30 Days FREE Trial $2008M 13.3x 0.8x
BWB Unlock Forecast - 30 Days FREE Trial $458M 12.6x 0.9x
BWBBP Unlock Forecast - 30 Days FREE Trial $536M 14.1x 1.1x
BWFG Unlock Forecast - 30 Days FREE Trial $341M 16.8x 1.2x
BY Unlock Forecast - 30 Days FREE Trial $1242M 10.9x 1.0x
CATY Unlock Forecast - 30 Days FREE Trial $3176M 11.1x 1.1x
CBAN Unlock Forecast - 30 Days FREE Trial $279M 10.5x 1.0x
CBFV Unlock Forecast - 30 Days FREE Trial $167M 14.4x 1.1x
CBSH Unlock Forecast - 30 Days FREE Trial $6537M 13.7x 2.7x
CCB Unlock Forecast - 30 Days FREE Trial $1587M 34.5x 3.4x
CCBG Unlock Forecast - 30 Days FREE Trial $674M 12.2x 1.3x
CCFN Unlock Forecast - 30 Days FREE Trial $186M 9.1x 1.1x
CCNE Unlock Forecast - 30 Days FREE Trial $509M 9.5x 0.8x
CCNEP Unlock Forecast - 30 Days FREE Trial $524M 9.6x 0.8x
CFFI Unlock Forecast - 30 Days FREE Trial $222M 9.0x 0.9x
CFG Unlock Forecast - 30 Days FREE Trial $21825M 13.9x 0.9x
CFG-PE Unlock Forecast - 30 Days FREE Trial $8745M 5.5x 0.4x
CFG-PH Unlock Forecast - 30 Days FREE Trial $11343M 7.1x 0.5x
CHMG Unlock Forecast - 30 Days FREE Trial $245M 22.7x 1.0x
CIVB Unlock Forecast - 30 Days FREE Trial $332M 10.8x 0.9x
CNOB Unlock Forecast - 30 Days FREE Trial $1202M 33.0x 0.8x
CNOBP Unlock Forecast - 30 Days FREE Trial $1212M 32.3x 0.8x
COFS Unlock Forecast - 30 Days FREE Trial $433M 29.4x 1.0x
COLB Unlock Forecast - 30 Days FREE Trial $5539M 10.2x 1.0x
COSO Unlock Forecast - 30 Days FREE Trial $227M x 1.1x
CPF Unlock Forecast - 30 Days FREE Trial $776M 13.1x 1.3x
CSBB Unlock Forecast - 30 Days FREE Trial $135M 10.5x 1.1x
CTBI Unlock Forecast - 30 Days FREE Trial $936M 10.5x 1.2x
CUBB Unlock Forecast - 30 Days FREE Trial $657M 4.5x 0.4x
CUBI Unlock Forecast - 30 Days FREE Trial $2133M 15.0x 1.1x
CUBI-PF Unlock Forecast - 30 Days FREE Trial $800M 5.4x 0.4x
CVBF Unlock Forecast - 30 Days FREE Trial $2559M 12.9x 1.1x
CWBC Unlock Forecast - 30 Days FREE Trial $406M 15.5x 1.1x
CZFS Unlock Forecast - 30 Days FREE Trial $260M 8.5x 0.8x
CZNC Unlock Forecast - 30 Days FREE Trial $302M 11.2x 1.1x
EBMT Unlock Forecast - 30 Days FREE Trial $134M 10.6x 0.7x
EFSC Unlock Forecast - 30 Days FREE Trial $1935M 10.1x 1.0x
EFSCP Unlock Forecast - 30 Days FREE Trial $740M 3.7x 0.4x
EFSI Unlock Forecast - 30 Days FREE Trial $201M 25.4x 1.1x
EGBN Unlock Forecast - 30 Days FREE Trial $511M -22.5x 0.4x
EMYB Unlock Forecast - 30 Days FREE Trial $132M 11.2x 1.2x
EQBK Unlock Forecast - 30 Days FREE Trial $723M 11.0x 1.1x
EWBC Unlock Forecast - 30 Days FREE Trial $13882M 11.9x 1.7x
FBIZ Unlock Forecast - 30 Days FREE Trial $409M 8.9x 1.2x
FBK Unlock Forecast - 30 Days FREE Trial $2466M 28.3x 1.5x
FBNC Unlock Forecast - 30 Days FREE Trial $2018M 20.6x 1.3x
FBP Unlock Forecast - 30 Days FREE Trial $3109M 10.7x 1.7x
FCBC Unlock Forecast - 30 Days FREE Trial $599M 12.3x 1.2x
FCCO Unlock Forecast - 30 Days FREE Trial $211M 12.2x 1.4x
FCNCA Unlock Forecast - 30 Days FREE Trial $23940M 9.8x 1.1x
FCNCB Unlock Forecast - 30 Days FREE Trial $20242M 8.5x 0.9x
FCNCO Unlock Forecast - 30 Days FREE Trial $302M 0.1x 0.0x
FCNCP Unlock Forecast - 30 Days FREE Trial $298M 0.1x 0.0x
FFIC Unlock Forecast - 30 Days FREE Trial $452M 19.5x 0.6x
FFIN Unlock Forecast - 30 Days FREE Trial $4393M 18.2x 2.5x
FFWM Unlock Forecast - 30 Days FREE Trial $436M -23.9x 0.4x
FHB Unlock Forecast - 30 Days FREE Trial $3050M 12.5x 1.1x
FIBK Unlock Forecast - 30 Days FREE Trial $3368M 14.5x 1.0x
FINW Unlock Forecast - 30 Days FREE Trial $251M 18.0x 1.4x
FITB Unlock Forecast - 30 Days FREE Trial $27303M 11.7x 1.3x
FITBI Unlock Forecast - 30 Days FREE Trial $17160M 7.3x 0.8x
FITBO Unlock Forecast - 30 Days FREE Trial $13595M 5.8x 0.6x
FITBP Unlock Forecast - 30 Days FREE Trial $16559M 7.1x 0.8x
FKYS Unlock Forecast - 30 Days FREE Trial $104M 13.4x 1.0x
FMBH Unlock Forecast - 30 Days FREE Trial $849M 10.6x 1.0x
FMBM Unlock Forecast - 30 Days FREE Trial $97M 11.4x 1.0x
FMNB Unlock Forecast - 30 Days FREE Trial $493M 10.0x 1.1x
FRAF Unlock Forecast - 30 Days FREE Trial $196M 13.5x 1.2x
FSBC Unlock Forecast - 30 Days FREE Trial $776M 14.7x 1.9x
FUSB Unlock Forecast - 30 Days FREE Trial $71M 12.2x 0.9x
FVCB Unlock Forecast - 30 Days FREE Trial $223M 11.3x 0.9x
FXNC Unlock Forecast - 30 Days FREE Trial $206M 25.9x 1.2x
GABC Unlock Forecast - 30 Days FREE Trial $1457M 17.1x 1.4x
GBCI Unlock Forecast - 30 Days FREE Trial $4821M 23.5x 1.4x
GBFH Unlock Forecast - 30 Days FREE Trial $527M 60.7x 3.5x
GSBC Unlock Forecast - 30 Days FREE Trial $638M 9.7x 1.0x
HBIA Unlock Forecast - 30 Days FREE Trial $706M 12.3x 1.4x
HBNC Unlock Forecast - 30 Days FREE Trial $697M 13.5x 0.9x
HBT Unlock Forecast - 30 Days FREE Trial $750M 10.3x 1.3x
HNVR Unlock Forecast - 30 Days FREE Trial $152M 13.3x 0.8x
HOMB Unlock Forecast - 30 Days FREE Trial $5252M 15.8x 1.3x
HONE Unlock Forecast - 30 Days FREE Trial $530M 21.7x 0.9x
HTBK Unlock Forecast - 30 Days FREE Trial $645M 15.6x 0.9x
HTH Unlock Forecast - 30 Days FREE Trial $1991M 13.0x 0.9x
HWC Unlock Forecast - 30 Days FREE Trial $4806M 13.1x 1.1x
HWCPZ Unlock Forecast - 30 Days FREE Trial $2076M 5.5x 0.5x
IBCP Unlock Forecast - 30 Days FREE Trial $639M 10.3x 1.4x
IBOC Unlock Forecast - 30 Days FREE Trial $4141M 10.2x 1.4x
INBK Unlock Forecast - 30 Days FREE Trial $174M 11.3x 0.5x
INBKZ Unlock Forecast - 30 Days FREE Trial $215M 13.9x 0.6x
INDB Unlock Forecast - 30 Days FREE Trial $2858M 15.6x 0.9x
ISBA Unlock Forecast - 30 Days FREE Trial $264M 16.3x 1.2x
ISTR Unlock Forecast - 30 Days FREE Trial $237M 10.9x 0.9x
JMSB Unlock Forecast - 30 Days FREE Trial $264M 14.5x 1.0x
LKFN Unlock Forecast - 30 Days FREE Trial $1443M 16.9x 1.9x
LNKB Unlock Forecast - 30 Days FREE Trial $261M 7.0x 0.9x
LOB Unlock Forecast - 30 Days FREE Trial $1449M 27.9x 1.4x
MBCN Unlock Forecast - 30 Days FREE Trial $266M 15.2x 1.2x
MBIN Unlock Forecast - 30 Days FREE Trial $1458M 6.0x 0.7x
MBINL Unlock Forecast - 30 Days FREE Trial $1072M 4.2x 0.5x
MBINM Unlock Forecast - 30 Days FREE Trial $1109M 4.4x 0.5x
MBINN Unlock Forecast - 30 Days FREE Trial $949M 3.8x 0.4x
MBWM Unlock Forecast - 30 Days FREE Trial $714M 9.1x 1.1x
MCB Unlock Forecast - 30 Days FREE Trial $700M 10.7x 1.0x
MCBS Unlock Forecast - 30 Days FREE Trial $656M 10.2x 1.5x
MNSB Unlock Forecast - 30 Days FREE Trial $149M 11.1x 0.7x
MNSBP Unlock Forecast - 30 Days FREE Trial $190M 13.3x 0.9x
MOFG Unlock Forecast - 30 Days FREE Trial $755M -84.8x 1.3x
MPB Unlock Forecast - 30 Days FREE Trial $661M 15.3x 0.9x
MSBI Unlock Forecast - 30 Days FREE Trial $347M 7.4x 0.6x
MTB Unlock Forecast - 30 Days FREE Trial $29106M 11.1x 1.0x
MTB-PH Unlock Forecast - 30 Days FREE Trial $4042M 1.5x 0.1x
MTB-PJ Unlock Forecast - 30 Days FREE Trial $4318M 1.6x 0.2x
MVBF Unlock Forecast - 30 Days FREE Trial $334M 19.9x 1.1x
MYFW Unlock Forecast - 30 Days FREE Trial $217M 18.7x 0.8x
NPB Unlock Forecast - 30 Days FREE Trial $551M 15.3x 0.9x
NTRS Unlock Forecast - 30 Days FREE Trial $24336M 14.0x 1.9x
NTRSO Unlock Forecast - 30 Days FREE Trial $3825M 2.2x 0.3x
NWFL Unlock Forecast - 30 Days FREE Trial $246M 77.6x 1.1x
NWPP Unlock Forecast - 30 Days FREE Trial $76M 8.2x 1.0x
OBK Unlock Forecast - 30 Days FREE Trial $1099M 15.0x 0.9x
OBT Unlock Forecast - 30 Days FREE Trial $318M 11.2x 1.3x
OFG Unlock Forecast - 30 Days FREE Trial $1721M 9.1x 1.3x
OPBK Unlock Forecast - 30 Days FREE Trial $203M 9.1x 1.0x
ORRF Unlock Forecast - 30 Days FREE Trial $652M 15.6x 1.2x
OSBC Unlock Forecast - 30 Days FREE Trial $823M 10.0x 1.2x
OVLY Unlock Forecast - 30 Days FREE Trial $231M 9.6x 1.2x
PB Unlock Forecast - 30 Days FREE Trial $6204M 11.6x 0.8x
PCB Unlock Forecast - 30 Days FREE Trial $301M 9.7x 0.8x
PEBK Unlock Forecast - 30 Days FREE Trial $172M 10.1x 1.2x
PEBO Unlock Forecast - 30 Days FREE Trial $1027M 10.2x 0.9x
PFBX Unlock Forecast - 30 Days FREE Trial $93M 4.8x 1.0x
PKBK Unlock Forecast - 30 Days FREE Trial $259M 8.6x 0.8x
PMHG Unlock Forecast - 30 Days FREE Trial $175M 21.5x 2.0x
QCRH Unlock Forecast - 30 Days FREE Trial $1242M 11.1x 1.2x
QNBC Unlock Forecast - 30 Days FREE Trial $129M 10.1x 1.1x
RBB Unlock Forecast - 30 Days FREE Trial $336M 14.9x 0.7x
RBCAA Unlock Forecast - 30 Days FREE Trial $1332M 11.1x 1.3x
RMBI Unlock Forecast - 30 Days FREE Trial $139M 14.6x 1.1x
RNST Unlock Forecast - 30 Days FREE Trial $3200M 20.8x 0.9x
RRBI Unlock Forecast - 30 Days FREE Trial $455M 13.0x 1.4x
RVRF Unlock Forecast - 30 Days FREE Trial $270M 7.0x 1.1x
SBCF Unlock Forecast - 30 Days FREE Trial $2651M 19.5x 1.2x
SBFG Unlock Forecast - 30 Days FREE Trial $125M 12.9x 0.9x
SBSI Unlock Forecast - 30 Days FREE Trial $855M 9.8x 1.0x
SFBS Unlock Forecast - 30 Days FREE Trial $3762M 15.5x 2.2x
SFDL Unlock Forecast - 30 Days FREE Trial $98M 8.5x 0.5x
SLBK Unlock Forecast - 30 Days FREE Trial $99M 9.1x 1.0x
SPFI Unlock Forecast - 30 Days FREE Trial $591M 11.4x 1.3x
SRCE Unlock Forecast - 30 Days FREE Trial $1449M 10.1x 1.2x
SSB Unlock Forecast - 30 Days FREE Trial $8967M 15.4x 1.0x
STBA Unlock Forecast - 30 Days FREE Trial $1379M 14.2x 1.0x
STT Unlock Forecast - 30 Days FREE Trial $33339M 11.7x 1.2x
STT-PG Unlock Forecast - 30 Days FREE Trial $6554M 2.3x 0.2x
SYBT Unlock Forecast - 30 Days FREE Trial $1958M 15.3x 2.0x
TCBI Unlock Forecast - 30 Days FREE Trial $3862M 13.2x 1.1x
TCBIO Unlock Forecast - 30 Days FREE Trial $953M 7.1x 0.3x
TCBK Unlock Forecast - 30 Days FREE Trial $1434M 12.6x 1.1x
TECTP Unlock Forecast - 30 Days FREE Trial $73M 4.5x 0.6x
TFIN Unlock Forecast - 30 Days FREE Trial $1327M 142.2x 1.4x
THFF Unlock Forecast - 30 Days FREE Trial $649M 14.3x 1.1x
TMP Unlock Forecast - 30 Days FREE Trial $919M 11.9x 1.3x
TRST Unlock Forecast - 30 Days FREE Trial $713M 13.3x 1.0x
TYFG Unlock Forecast - 30 Days FREE Trial $111M x 0.7x
UBSI Unlock Forecast - 30 Days FREE Trial $5099M 13.2x 1.0x
UCB Unlock Forecast - 30 Days FREE Trial $3549M 13.3x 1.0x
UCB-PI Unlock Forecast - 30 Days FREE Trial $3035M 11.1x 0.8x
UNTY Unlock Forecast - 30 Days FREE Trial $459M 9.5x 1.4x
UVSP Unlock Forecast - 30 Days FREE Trial $850M 10.2x 0.9x
UWHR Unlock Forecast - 30 Days FREE Trial $73M 7.2x 1.3x
VBTX Unlock Forecast - 30 Days FREE Trial $3308M 28.6x 2.0x
WAL Unlock Forecast - 30 Days FREE Trial $8343M 10.2x 1.2x
WAL-PA Unlock Forecast - 30 Days FREE Trial $2343M 2.8x 0.3x
WASH Unlock Forecast - 30 Days FREE Trial $529M 13.8x 1.0x
WTBA Unlock Forecast - 30 Days FREE Trial $363M 11.0x 1.4x
WTFC Unlock Forecast - 30 Days FREE Trial $8637M 11.7x 1.2x
WTFCN Unlock Forecast - 30 Days FREE Trial $1780M 2.4x 0.3x

Frequently Asked Questions - S&T BANCORP INC Stock Forecast

How accurate are S&T BANCORP INC stock predictions?

Our AI model shows a 19% Spearman correlation coefficient for STBA predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence S&T BANCORP INC stock price forecasts?

Our analysis considers S&T BANCORP INC's financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is S&T BANCORP INC a good investment in 2025?

Based on our AI analysis, S&T BANCORP INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are S&T BANCORP INC forecasts updated?

S&T BANCORP INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced S&T BANCORP INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for S&T BANCORP INC stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...